OnDemand: July 2025 Grand Rounds - Metabolic Surgery to Treat the Complications of Obesity

Obesity is associated with over 200 medical conditions. Metabolic surgery is a powerful tool that can help prevent and even reverse many of these serious health consequences. Join us for this educational webinar to explore how surgical interventions support long-term metabolic health, improve quality of life, and reduce obesity-related complications. Learn about the different types of metabolic surgery, safety of the procedures, and the role of surgery in comprehensive obesity treatment.

After participating in this webinar, learners will be able to describe the different types of metabolic surgery and their mechanisms of action in the treatment of obesity.

After participating in this webinar, participants will be able to evaluate the safety profiles, risks, and outcomes associated with commonly performed metabolic surgical procedures.

After participating in this webinar, participants will be able to explain the short- and long-term health benefits of metabolic surgery and its role within a comprehensive obesity treatment plan.

Ali Aminian, MD, FACS, FASMBS

Professor of Surgery, MD, FACS, FASMBS

Ali Aminian, M.D. is Director of Bariatric and Metabolic Institute at the Cleveland Clinic and a Professor of Surgery at the Cleveland Clinic Lerner College of Medicine. He has an outstanding record of peer-reviewed publications (>250) in high impact journals including New England Journal of Medicine, JAMA, Nature Medicine, Diabetes Care, and Annals of Surgery. His studies have been widely covered by the media such as New York Times, Wall Street Journal, Washington Post, TIME, CNN, Reuters, Newsweek, and Forbes, indicating their importance from public health perspective.

The Obesity Society is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Obesity Society designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ACCME Activity ID 203263468

Date of Release: August 1, 2025
Date of Termination: December 31, 2027

No commercial support was received for this activity.

Ali Aminian, MD, FACS, FASMBS: Advisor relationship with Eli Lilly (Pharmaceuticals) and Ethicon (Medical Device). Consultant relationship with Medtronic (Medical Device). Researcher relationship with Ethicon (Medical Device) and Medtronic (Medical Device).

Monica Agarwal, MD, MEHP, FACE: No relevant financial relationships

No members of the TOS CME Oversight Committee, charged with the resolution of all relevant conflicts of interest, had any relevant financial relationships while serving on the committee.

1. Aminian A, Zajichek A, Arterburn DE, Wolski KE, Brethauer SA, Schauer PR, Kattan MW, Nissen SE. Association of Metabolic Surgery With Major Adverse Cardiovascular Outcomes in Patients With Type 2 Diabetes and Obesity. JAMA. 2019 Oct 1;322(13):1271-1282. doi: 10.1001/jama.2019.14231. PMID: 31475297; PMCID: PMC6724187.

2. Brethauer SA, Aminian A, Romero-Talamás H, Batayyah E, Mackey J, Kennedy L, Kashyap SR, Kirwan JP, Rogula T, Kroh M, Chand B, Schauer PR. Can diabetes be surgically cured? Long-term metabolic effects of bariatric surgery in obese patients with type 2 diabetes mellitus. Ann Surg. 2013 Oct;258(4):628-36; discussion 636-7. doi: 10.1097/SLA.0b013e3182a5034b. PMID: 24018646; PMCID: PMC4110959.

3. Aminian A, Daigle CR, Romero-Talamás H, Kashyap SR, Kirwan JP, Brethauer SA, Schauer PR. Risk prediction of complications of metabolic syndrome before and 6 years after gastric bypass. Surg Obes Relat Dis. 2014 Jul- Aug;10(4):576-82. doi: 10.1016/j.soard.2014.01.025. Epub 2014 Jan 29. PMID: 24837561.